慢性病中的降脂疗法:呼吁采取行动
Jaime Mazón-Ruiz1, David Arroyo2, Marina de Cos3
1Nephrology Department, Hospital Carmen y Severo Ochoa, Cangas del Narcea, Spain.
Atherosclerosis
|November 21, 2025
概括
患有慢性病 (CKD) 的患者患有高心血管风险,但用降脂疗法 (LLT) 治疗不足. 需要更多的研究,以优化这种人群的失脂症管理.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 临床试验 临床试验
背景情况:
- 动脉样性心血管疾病 (ASCVD) 是慢性病 (CKD) 患者的主要死亡原因.
- 慢性病患者的心血管事件发生率高于一般人群.
- 降脂疗法 (LLT) 在CKD患者中不足以用于预防心血管事件.
研究的目的:
- 系统地审查关于在慢性病患者中预防ASCVD的LLT的证据.
- 为了确定随机临床试验 (RCT) 关于CKD患者纳入的差距.
- 突出在CKD中需要量身定制的脂质管理策略.
主要方法:
- 对现有文献进行系统审查.
- 在评价LLT的RCT中分析CKD患者代表性的分析.
- 根据现有证据评估当前的治疗指南.
主要成果:
- 在LLT的RCT中,CKD患者的代表性明显不足.
- 目前对慢性脏疾病中的失脂症的治疗建议通常依赖于外推的数据.
- 在这个高危人群中,有效的脂质管理存在证据缺口.
结论:
- 专门的临床试验对于解决CKD患者的特定脂质管理需求至关重要.
- 在CKD人群中优化LLT对于降低心血管风险至关重要.
- 需要进一步的研究,通过有针对性的干预措施改善慢性病患者的心血管结果.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Chronic Kidney Disease III: Interprofessional Care
326
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
326
Chronic Kidney Disease II: Clinical Manifestations
531
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
531
Chronic Kidney Disease I: Introduction
549
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
549
Acute Kidney Injury V: Interprofessional Care
284
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
284
Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301


